Tigermed
Tigermed is a contract research company providing whole process clinical trial services for the R&D of pharmaceuticals.
Tigermed, founded in December, 2014 and headquartered in Hangzhou, is a contract research organization (CRO) focused on providing professional services for the entire process of clinical trials for new drug research. The founder is Ye Xiaoping. Listed on the SZSE on August 17, 2012, the company's major shareholders are Ye Xiaoping, Hong Kong Securities Clearing Co., Ltd and Cao Xiaochun. Rivals that have direct and indirect competition with Tigermed include Kintor, HitGen, Aprea Therapeutics, BridgeBio Pharma, etc.
Bh009 new drug project independently researched and developed by Beihai biological Co., Ltd. was approved by China's clinical trials
Tiger pharmaceutical performance forecast: net profit in 2020 will increase by 100% - 115% year on year
Focus on high-throughput single-cell omics platform products, search for a reason to complete more than 100 million yuan round a financing
Another protein component special medical food was approved, and the total number of approved products increased to 57
Research
Technology, Consumer Staples, HealthcareWIA2020 | Rising Tech Stars 2020: Global & China's 100
Research
Consumer Staples, Real Estate, HealthcareTech for Global, Globalization Footprints of the Established and the New
Research
Consumer Staples, Real Estate, HealthcareLow-Carbon Industry Expansion - Key Studies From Chinese Companies
Improving service quality and enabling industrial innovation!
Plan to raise $4 billion! Jingdong health runs IPO
Drug Innovator Asieris Nabs CNY 700 Million Series D
AI-Based Drug Research Platform XtalPi Closes Series C at USD 318.8 Mn
WIM2020: Insights on the Post-pandemic Outlook for the Healthcare Industry
The curtain came down on Dec 10 on the 'Healthtech Industry and COVID-19 Pandemic' Chapter at WIM 2020. Healthtech entrepreneurs and investors gathered to share insights on the outlook for the healthcare industry, covering topics like vaccination, AI healthcare, intelligent hardware, medical appliances and IVD.
Jan 07, 2021 02:10 PM
WIM2020: Uniting the World through Technology and Innovation
On December 9-12, EqualOcean held the World Innovators Meet (WIM) 2020. This year, the event's main topic was 'Technology and Innovation Connect the World.' WIM2020 gathered innovators from Asia, Africa, Europe and North America to share their knowledge and key achievements, promoting the concept of 'Tech for Equal.'
Dec 17, 2020 07:53 PM
Top-Tier CDMO Heyuan China Closes Series C at over CNY 300 Mn
Nasdaq-listed Biotech ZLAB Passes the Hearing for Hong Kong IPO
Genor Biopharma Passes the Hearing for Hong Kong IPO
WuXi AppTec: A Favorable Chinese Stock for MSCI and FTSE Russell
According to the latest quarterly index review, a Wuxi-based CRO company will be incorporated into the FTSE China A 50 Share Index. It has been considered a top holding by many MSCI China indexes for some time.
Jun 08, 2020 09:51 AM
Tigermed Invests in Tongli Biomedical to Treat Parasitic Zoonoses
Chinese Biopharma Adlai Nortye Closes Series C at USD 100 Mn
ConSino Grants the First Chinese COVID-19 Vaccine Patent
TigerMed: New to be the Third Dual-listed CRO on HKEX and A-share